Form 4: Neuraxis Insider Buys Shares

Neuraxis CRO, CCO, CPO Thomas Carrico acquired 667 shares of common stock at $1.96 per share.

Summary

• Thomas Carrico, identified as CRO, CCO, and CPO of Neuraxis, Inc., purchased 667 shares of common stock.
• The transaction occurred on April 1, 2026, with shares acquired at a price of $1.96 each.
• Following this acquisition, Mr. Carrico beneficially owns 331,903 shares of Neuraxis common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive signal due to the insider purchase, indicating management confidence, though the transaction size is relatively small.

Positives

• Insider purchase of company stock by a key executive (CRO, CCO, CPO).
• The purchase indicates a potential belief in the company's future prospects by management.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that insider buying, particularly by executive officers, can be a signal of confidence in the company's valuation and future performance within the biotechnology sector.

Stakeholder Impact

• Shareholders may view this insider purchase positively, interpreting it as a sign of management's confidence in the company's value.
• Employees may also see this as a positive indicator for the company's stability and future prospects.

Key Dates

Recommendation

The purchase of a small number of shares by an executive is a positive signal but not substantial enough on its own to warrant a strong buy or sell recommendation. It suggests management confidence, but further analysis of the company's overall financial health and strategic direction is needed.

Keywords

Neuraxis, NRXS, Form 4, Insider Trading, Stock Purchase, Beneficial Ownership, Executive Compensation